Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients

American Journal of Cardiology

Volumn 81, Issue 12 A, 1998, Pages 21G-28G

  Anselmi, Maurizio ^a,b   Golia, Giorgio ^a   Cicoira, Mariantonietta ^a   Tinto, Monica ^a   Nitti, Maria Teresa ^a   Trappolin, Roberto ^a   Rossi, Andrea ^a   Zanolla, Luisa ^a   Marino, Paolo ^a   Zardini, Piero ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Div Clinicizzata di Chir Generale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ADULT; AGED; CONFERENCE PAPER; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART INFARCTION; HEART MUSCLE CONTRACTILE FORCE; HEART PERFORMANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING;

EID: 0032543534     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00049-6     Document Type: Conference Paper

References (57)

1. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G, the Ad hoc Working Group of the GISSI-2 Data Base. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 Data Base. Circulation 1993;88: 416-429.
2. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-336.
3. Braunwald E, Kloner RA. The stunned myocardium: prolonged, post-ischemic ventricular dysfunction. Circulation 1982;66:1146-1149.
4. Bolli R. Myocardial "stunning" in man. Circulation 1992;86:1671-1691.
5. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-221.
6. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction. Evidence for the "hibernating myocardium." J Am Coll Cardiol 1986;8:1467-1470.
7. Brundage BH, Massie BM, Botvinick E. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol 1984;4:902-908.
8. Van den Berg EK, Popma JJ, Dehmer GJ, Snow FR, Lewis SA, Vetrovec GW, Nixon JV. Reversible segmental left ventricular dysfunction after coronary angioplasty. Circulation 1990;81:1210-1216.
9. Montalescot G, Faraggi M, Drobinski G, Messian O, Evans J, Grosgogeat Y, Thomas D. Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Circulation 1992;86:47-55.
10. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
11. Baer FM, Voth E, Deutsch H, Schneider CA, Horst M, de Vivie ER, Schicha H, Erdmann E, Sechtem U. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 1996;28:60-69.
12. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
13. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201 Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87:1630-1641.
14. Perrone-Filardi P, Pace L, Prastaro M, Squame F, Betocchi S, Soricelli A, Piscione F, Indolfi C, Crisci T, Salvatore M, Chiariello M. Assessment of myocardial viability in patients with chronic coronary artery disease. Circulation 1996;94:2712-2719.
15. Perrone-Filardi P, Pace L, Prastaro L, Piscione F, Betocchi S, Squame F, Vezzuto P, Soricelli A, Indolfi C, Salvatore M, Chiariello M. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995;91:2556-2565.
16. Cigarroa CG, de Filippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-436.
17. Arnese M, Cornel JH, Salustri A, Maat APWM, Elhendy A, Reijs AEM, Cate FJT, Keane D, Balk A, Roelandt J, Fioretti P. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201 TI single-photon emission computed tomography. Circulation 1995;91:2748-2752.
18. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-1531.
19. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-626.
20. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkoviz K, Bourdillon PDV, Feigenbaum H. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-415.
21. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy. Comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-1031.
22. Ragosta M, Camarano G, Kaul S, Powers ER, Sarembock IJ, Gimple LW. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation 1994;89:2562-2569.
23. Camarano G, Ragosta M, Gimple LW, Powers ER, Kaul S. Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction. Am J Cardiol 1995;75:215-219.
24. Ito H, Tomooka T, Sakai N, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-1705.
25. De Filippi CR, Willett DL, Irani WN, Eichhorn EJ, Velasco CE, Grayburn PA. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995;92:2863-2868.
26. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, MacIntyre WJ, Thomas JD. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-2694.
27. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H, Hawkins R, Schelbert HR, Phelps ME, Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-533.
28. Eitzman D, Al Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-565.
29. Tamaki N, Kawamoto M, Takahashi N, Yonekura Y, Magata Y, Nohara R, Kambara H, Sasayama S, Hirata S, Ban T, Konishi J. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993;22:1621-1627.
30. Yoshida K, Gould L. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993;22:984-997.
31. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996;27:132-139.
32. Marino P, Zanolla L, Zardini P. Effect of streptokinase on left ventricular remodeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo studio della Streptochinasi nell'infarto miocardico) trial. J Am Coll Cardiol 1989;14:1149-1158.
33. Bonow R. Identification of viable myocardium. Circulation 1996;94:2674-2680.
34. Beller G. Comparison of 201 TI scintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability. Circulation 1996;94:2681-2684.
35. McGhie AI, Weyman A. Searching for hibernating myocardium. Time to reevaluate investigative strategies? Circulation 1996;94:2685-2688.
36. Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 1995;75:759-762.
37. Pagley PR, Beller G, Watson DD, Gimple LW, Ragosta M. Extent of myocardial viability by resting Thallium-201 scintigraphy determines early surgical outcome in ischemic cardiomyopathy. (Abstr.) Circulation 1995;92(suppl I):I-522.
38. Pasquet A, Gerber B, D'Hondt AM, De Kock M, Melin JA, Vanoverschelde JL. Value of dobutamine echocardiography and FDC-PET in evaluating prognosis in patients with chronic left ventricular ischemic dysfunction. (Abstr.) Circulation 1995;92(suppl I):I-268.
39. Sicari R, Vassalle C, Torres MA, Pingitore A, Bigi R, Coletta C, Heyman J, Casazza F, Previtali M, Wilson M, Minardi G, Lowestein J, Salustri A, Morales MA, Picano E, on behalf of EDIC. The prognostic value of myocardial viability early after myocardial infarction: a dobutamine stress echo study. (Abstr.) Circulation 1995(suppl I):I-267.
40. Nijland F, Kamp O, Verhorst PMJ, De Voogt WG, Carcagni A, Visser CA. Prognostic implications of low dose dobutamine echocardiography early after acute myocardial infarction. (Abstr.) Circulation 1996;94(suppl I):I-679.
41. Novak WV, Sawada SG, Lewis SJ, Foltz J, Brenneman P, Bates JR, DS Segar, Feigenbaum H. Extent of nonviable myocardium by dobutamine echocardiography predicts death in ischemic cardiomyopathy. (Abstr.) J Am Coll Cardiol 1996;27(suppl I):I-329.
42. Pingitore A, Vassalle C, Sicari R, Bigi R, Seveso G, Salustri A, Lowenstein J, Heyman J, Mattioli R, Wilson M, Michelassi C. Viability improves survival in severe acute left ventricular dysfunction: a dobutamine stress echo study. (Abstr.) Circulation 1996;94(suppl I):I-83.
43. Luciani GB, Faggian G, Razzolini R, Livi U, Bortolotti U, Mazzucco A. Severe ischemic left ventricular failure: coronary operation or heart transplantation? Ann Thorac Surg 1993;55:719-723.
44. Bell MR, Gersh BJ, Schaff HV, Holmes DR, Fisher LD, Alderman EL, Myers WO, Parsons LS, Reeder GS, and the Investigators of the Coronary Artery Surgery Study. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation 1992;86:446-457.
45. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831-836.
46. Bounous EP, Mark DB, Pollock BG, Hlatky MA, Harrell FE, Lee KL, Scott Rankin J, Wechsler AS, Pryor DB, Califf R. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 1988; 78(suppl I):I-151-I-157.
47. Passamani E, Davis KB, Gillespie MJ, Killip T and the CASS principal investigators and their associates. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985; 312:1665-1671.
48. Mickleborough LL, Maruyama H, Takagi Y, Mohamed S, Sun Z, Ebisuzaki L. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995;92(suppl II):II-73-II-79.
49. Elefteriades JA, Tolis G, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993;22: 1411-1417.
50. Nesto RW, Cohn L, Collins JJ, Wynne J, Holman L, Cohn PF. Inotropic contractile reserve: a useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol 1982;50:39-44.
51. Vanoverschelde JLJ, Gerber BL, D'Hondt AM, De Kock M, Dion R, Wijns W, Melin JA. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization. Circulation 1995;92(suppl II):II-37-II-44.
52. Louie HW, Laks H, Drinkwater DC, Hamilton MA, Brunken RC, Stevenson LW. Ischemic cardiomyopathy: criteria for coronary revascularization and cardiac transplantation. Circulation 1991;84(suppl III):III-290-III-295.
53. Kaul S. There may be more to myocardial viability than meets the eye! Circulation 1995;92:2790-2793.
54. Kaul S. Response of dysfunctional myocardium to dobutamine. "The eyes see what the mind knows!" J Am Coll Cardiol 1996;27:1608-1611.
55. Vanoverschelde JLJ, Wijns W, Borgers M, Heyndrickx G, Depré C, Flameng W, Melin JA. Chronic myocardial hibernation in humans. From bedside to bench. Circulation 1997;95:1961-1971.
56. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-670.
57. Chen C, Chen LL, Prada J, Chen MH, Fallon JT, Weyman AE, Waters D, Gillam L. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation 1995;92:756-766.